Steven Leach named director at Dartmouth Norris Cotton Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Steven Leach was named director of the Norris Cotton Cancer Center. He will begin his role in September.

Leach will oversee a program that combines cancer research at Dartmouth and the Geisel School of Medicine with cancer care provided across the Dartmouth-Hitchcock health system.
Leach is the David M. Rubenstein Chair and director of the Rubenstein Center for Pancreatic Cancer Research at Memorial Sloan Kettering Cancer Center.

Leach has spent the past 25 years conducting both basic science and clinical research, becoming the inaugural director of MSK’s pancreatic cancer research center in 2014. He is also a professor of surgery at Weill Medical College of Cornell University.

He previously served as the Paul K. Neumann Professor in Pancreatic Cancer Research, professor of surgery, oncology and cell biology, chief of the Division of Surgical Oncology and vice chair for academic affairs at Johns Hopkins University.

In addition to his appointment as the director of the NCCC, Leach will hold the Preston T. and Virginia R. Kelsey Distinguished Chair in Cancer at the Geisel School of Medicine at Dartmouth. This chair supports the director of the NCCC in advancing innovative research that translates into clinical and preventative cancer care.

Leach will continue his research into pancreatic cancer biology. His lab at MSK has made discoveries that have established previously unrecognized links between pancreatic development and pancreatic cancer.

More recently, Leach’s team has completed highly translational studies focused on more advanced stages of the disease, including the development of novel models for testing the drug sensitivity of each patient’s individual tumor.

YOU MAY BE INTERESTED IN

Those of us who have devoted our careers to treating recalcitrant cancers know the heartbreak of walking alongside an individual facing an advanced diagnosis. We not only shoulder the clinical responsibility, but also the emotional weight that accompanies every step of that journey as each patient’s story becomes connected to our own.
If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.
In a poignant keynote punctuated with anecdotes about grief, American Society of Clinical Oncology’s immediate past president Eric Small emphasized that the annual conference is not just about scientific discovery, but about a responsibility to translate discoveries into better outcomes for cancer patients globally. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login